Chart

Aligos Therapeutics, Inc.

ALGS

Jan 1 1970 00:00:00

9.24

▲0.25▲2.78%

Open9.12

High9.47

Low9.12

Close8.99

Volume1.27k

EPS

-10.24

P/E

-0.9023

Market Cap

393.71M

Outstanding Shares

42.61M

Soon

Sentiment

Soon

Options

Recent Filings

ID: 0001610717-24-000503

ID: 0001610717-24-000495

ID: 0001783647-24-000001

ID: 0001610717-24-000466

ID: 0001610717-24-000465

ID: 0001610717-24-000464

ID: 0001193125-24-214188

ID: 0001193125-24-202813

ID: 0001610717-24-000423

ID: 0001610717-24-000422

You might find these companies interesting

Lenz Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Evaxion Biotech A/s

Biological Products, (No Diagnostic Substances) (2836)

Biological Products, (No Diagnostic Substances) (2836)

Adma Biologics, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Biological Products, (No Diagnostic Substances) (2836)

Biological Products, (No Diagnostic Substances) (2836)

Scilex Holding Co

Biological Products, (No Diagnostic Substances) (2836)

Passage Bio, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Editas Medicine, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Outlook Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Adaptive Biotechnologies Corp

Biological Products, (No Diagnostic Substances) (2836)

Voyager Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) (2836)

Cambell International Holding Corp.

Medicinal Chemicals & Botanical Products (2833)

Gossamer Bio, Inc.

Pharmaceutical Preparations (2834)